Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors-Reference-Cited by-同舟云学术

Detection of EGFR mutations in plasma DNA from lung cancer patients by mass spectrometry genotyping is predictive of tumor EGFR status and response to EGFR inhibitors

Published:2011-07 Issue:1 Volume:73 Page:96-102
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Brevet Marie,Johnson Melissa L.,Azzoli Christopher G.,Ladanyi Marc

Funder

NIH P01 grant

the Gretchen and Samuel Feldman Fellowship

La Fondation de France

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference21 articles.

1. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma;Mok;N Engl J Med,2009

2. Quantification of free circulating DNA as a diagnostic marker in lung cancer;Sozzi;J Clin Oncol,2003

3. Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-small-cell lung cancer;Bai;J Clin Oncol,2009

4. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients;Yung;Clin Cancer Res,2009

5. EGFR mutations detected in plasma are associated with patient outcomes in erlotinib plus docetaxel-treated non-small cell lung cancer;Mack;J Thorac Oncol,2009

Cited by 104 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study);Cancers;2023-10-16

2. Recent advances in the detection of glioblastoma, from imaging-based methods to proteomics and biosensors: A narrative review;Cancer Cell International;2023-05-20

3. Non-small-cell lung cancer-associated gene mutations and inhibitors;Advances in Cancer Biology - Metastasis;2022-12

4. Liquid biopsy in lung cancer management;Romanian Journal of Morphology and Embryology;2022-09-09

5. Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS;Nature Communications;2021-06-18